Covered recipient · General Payments record
CHARLES L VOGEL
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2023
$17,918.90
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Long term medical supply or device loan | $249.99 | 3 |
| Food and Beverage | $76.64 | 4 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $298.80 | 5 |
| Lilly USA, LLC | $27.83 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Lilly USA, LLC | $12.78 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031314747 | CMS |
| Lilly USA, LLC | $15.05 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031299969 | CMS |
| Novartis Pharmaceuticals Corporation | $26.93 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993329143 | CMS |
| Novartis Pharmaceuticals Corporation | $21.88 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993329149 | CMS |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.33 | 01/14/2023 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 993431463 | CMS |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.33 | 02/15/2023 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 993431465 | CMS |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.33 | 05/31/2023 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 993431467 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.